Recent Analysts’ Ratings Updates for Docusign (DOCU)

Docusign (NASDAQ: DOCU) recently received a number of ratings updates from brokerages and research firms:

  • 3/18/2026 – Docusign had its price target lowered by Citigroup Inc. from $120.00 to $99.00. They now have a “buy” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by JPMorgan Chase & Co. from $78.00 to $65.00. They now have a “neutral” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Piper Sandler from $75.00 to $52.00. They now have a “neutral” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Morgan Stanley from $90.00 to $69.00. They now have an “equal weight” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Royal Bank Of Canada from $70.00 to $55.00. They now have a “sector perform” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by UBS Group AG from $75.00 to $54.00. They now have a “neutral” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Citizens Jmp from $124.00 to $86.00. They now have a “market outperform” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Robert W. Baird from $75.00 to $55.00. They now have a “neutral” rating on the stock.
  • 3/18/2026 – Docusign had its price target lowered by Wells Fargo & Company from $75.00 to $60.00. They now have an “equal weight” rating on the stock.
  • 3/18/2026 – Docusign had its “buy” rating reaffirmed by BTIG Research. They now have a $70.00 price target on the stock.
  • 3/10/2026 – Docusign had its “hold” rating reaffirmed by Needham & Company LLC.
  • 3/2/2026 – Docusign had its “market outperform” rating reaffirmed by Citigroup Inc..
  • 2/23/2026 – Docusign was downgraded by Jefferies Financial Group Inc. from “buy” to “hold”. They now have a $45.00 price target on the stock, down from $105.00.
  • 2/18/2026 – Docusign had its price target lowered by BTIG Research from $88.00 to $70.00. They now have a “buy” rating on the stock.
  • 2/13/2026 – Docusign was given a new $53.00 price target by HSBC Holdings plc.

Insiders Place Their Bets

In other Docusign news, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the completion of the sale, the insider owned 54,550 shares in the company, valued at $3,656,486.50. The trade was a 18.03% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Robert Chatwani sold 16,696 shares of the business’s stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $48.10, for a total transaction of $803,077.60. Following the completion of the sale, the insider directly owned 72,458 shares of the company’s stock, valued at $3,485,229.80. This represents a 18.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 68,173 shares of company stock worth $4,324,684. 1.01% of the stock is currently owned by insiders.

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Articles

Receive News & Ratings for Docusign Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign Inc and related companies with MarketBeat.com's FREE daily email newsletter.